M. Andersen

发表

Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8

L. Kjeldsen, J. Pedersen‐Bjergaard, K. Brøndum‐Nielsen, 2002, Leukemia.

Invited lecture: Insights into leukemogenesis from cytogenetic and molecular studies of therapy-related myelodysplasia and acute myeloid leukemia

D. Christiansen, M. Andersen, 2006 .

Increased frequency of dicentric chromosomes in therapy-related MDS and AML compared to de novo disease is significantly related to previous treatment with alkylating agents and suggests a specific susceptibility to chromosome breakage at the centromere

J. Pedersen‐Bjergaard, M. Andersen, 2000, Leukemia.

Concurrent disruption of cell cycle associated genes in mantle cell lymphoma: a genotypic and phenotypic study of cyclin D1, p16, p15, p53 and pRb

P. Guldberg, K. Grønbæk, N. E. Hansen, 1998, Leukemia.

Genetics of therapy-related myelodysplasia and acute myeloid leukemia

D. Christiansen, J. Pedersen‐Bjergaard, M. Andersen, 2008, Leukemia.

Causality of myelodysplasia and acute myeloid leukemia and their genetic abnormalities

D. Christiansen, J. Pedersen‐Bjergaard, F. Skovby, 2002, Leukemia.

Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity.

P. Guldberg, K. Grønbæk, N. E. Hansen, 1998, Blood.

NPM1 mutations in therapy-related acute myeloid leukemia with uncharacteristic features

D. Christiansen, J. Pedersen‐Bjergaard, M. Andersen, 2008, Leukemia.

Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia

D. Christiansen, M. Andersen, J. Pedersen‐Bjergaard, 2003, Leukemia.